Viatris Inc. (VTRS)

NASDAQ: VTRS · IEX Real-Time Price · USD
11.94
+0.11 (0.93%)
At close: Mar 28, 2024, 4:00 PM
12.00
+0.06 (0.50%)
After-hours: Mar 28, 2024, 7:02 PM EDT

Company Description

Viatris Inc. operates as a healthcare company worldwide.

The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health.

It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions.

The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names.

The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Viatris Inc.
Viatris logo
Country United States
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 38,000
CEO Scott Andrew Smith

Contact Details

Address:
1000 Mylan Boulevard
Canonsburg, Pennsylvania 15317
United States
Phone (724) 514-1465
Website viatris.com

Stock Details

Ticker Symbol VTRS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001792044
CUSIP Number 92556V106
ISIN Number US92556V1061
Employer ID 83-4364296
SIC Code 2834

Key Executives

Name Position
Scott Andrew Smith Chief Executive Officer and Director
Rajiv Malik President and Executive Director
Anthony Mauro President of Developed Markets
Theodora Mistras Chief Financial Officer
Sanjeev Kumar Sethi Chief Operating Officer
Paul B. Campbell Chief Accounting Officer, Senior Vice President and Corporate Controller

Latest SEC Filings

Date Type Title
Mar 11, 2024 144 Filing
Mar 5, 2024 144 Filing
Mar 5, 2024 144 Filing
Mar 4, 2024 144 Filing
Feb 28, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report
Feb 23, 2024 144 Filing
Feb 15, 2024 144 Filing
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals